EXPRS2 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ExpreS2ion Biotech Holding AB

Watchlist Manager

Watchlist

Price: 1.59 SEK -0.93%

Market Cap: kr37.2m

E	ExpreS2ion Biotech Holding AB STO:EXPRS2	SE
	Globe Life Inc NYSE:GL	US
	TE Connectivity Ltd NYSE:TEL	CH
	Packaging Corp of America NYSE:PKG	US
I	International Seaways Inc F:IS5	US
	Ingersoll Rand Inc NYSE:IR	US
N	Nintendo Co Ltd XMUN:NTO	JP
	Airbus SE XETRA:AIR	NL
	Tompkins Financial Corp F:8J0	US
F	Foschini Group Ltd JSE:TFG	ZA

Profitability Summary

ExpreS2ion Biotech Holding AB's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

71%

Negative 3Y Average Gross Margin

-63%

Gross Margin is Increasing

-209% > 71%

Negative Operating Margin

-363%

Negative 3Y Average Operating Margin

-877%

Operating Margin is Increasing

-2 145% > -363%

Negative Net Margin

-312%

Negative 3Y Average Net Margin

-650%

Net Margin is Increasing

-1 968% > -312%

Negative Free Cash Flow Margin

-335%

Negative 3Y Average Free Cash Flow Margin

-818%

Free Cash Flow Margin is Increasing

-1 884% > -335%

Negative ROE

-76%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-327%

ROIC is Increasing

-763% > -269%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.